Skip to main content
The BMJ logoLink to The BMJ
. 1994 Dec 17;309(6969):1605–1607. doi: 10.1136/bmj.309.6969.1605

Heart muscle disease related to HIV infection: prognostic implications.

P F Currie 1, A J Jacob 1, A R Foreman 1, R A Elton 1, R P Brettle 1, N A Boon 1
PMCID: PMC2542022  PMID: 7819934

Abstract

OBJECTIVES--To determine the natural course of heart muscle disease in patients infected with HIV. DESIGN--Prospective echocardiographic survey and observational study over four years. SETTING--Edinburgh. SUBJECTS--296 adults infected with HIV (mean age 32.7 years (range 21.5 to 67.6) drawn from all the major groups at risk of HIV infection in Britain. MAIN OUTCOME MEASURES--Detection of myocardial dysfunction and time to death from index echocardiogram in serial echocardiography. RESULTS--Cardiac dysfunction was identified in 44 subjects (dilated cardiomyopathy, 13; isolated right ventricular dysfunction, 12; borderline left ventricular dysfunction, 19). Dilated cardiomyopathy was strongly associated with a CD4 cell count of < 100 x 10(6)/l, in contrast with the other forms of cardiac dysfunction. During the study 12/13 (92%) subjects with dilated cardiomyopathy, 5/12 (42%) with right ventricular dysfunction, and 8/19 (42%) with borderline left ventricular function died of conditions related to AIDS. Survival was significantly reduced in the subjects with dilated cardiomyopathy compared with those with normal hearts (P < 0.001). The median survival from the index echocardiogram was 101 days (95% confidence interval 42 to 146) for the subjects with cardiomyopathy compared with 472 days (383 to 560) for those with normal hearts and a CD4 cell count of < 20 x 10(6)/l. No significant difference existed in survival for subjects with borderline left or isolated right ventricular dysfunction. CONCLUSION--Even after adjustment for the significantly reduced CD4 cell count with which dilated cardiomyopathy is associated, the outlook for patients with HIV infection and dilated cardiomyopathy is poor. Isolated right and borderline left ventricular dysfunction are not associated with reduced CD4 cells counts and do not carry adverse prognostic implications.

Full text

PDF
1605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acierno L. J. Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review. J Am Coll Cardiol. 1989 Apr;13(5):1144–1154. doi: 10.1016/0735-1097(89)90277-5. [DOI] [PubMed] [Google Scholar]
  2. Centers for Disease Control (CDC) Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep. 1986 May 23;35(20):334–339. [PubMed] [Google Scholar]
  3. Currie P. F., Boon N. A. Cardiac involvement in human immunodeficiency virus infection. Q J Med. 1993 Dec;86(12):751–753. [PubMed] [Google Scholar]
  4. Goedert J. J., Biggar R. J., Melbye M., Mann D. L., Wilson S., Gail M. H., Grossman R. J., DiGioia R. A., Sanchez W. C., Weiss S. H. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA. 1987 Jan 16;257(3):331–334. [PubMed] [Google Scholar]
  5. Greenspan D., Greenspan J. S., Hearst N. G., Pan L. Z., Conant M. A., Abrams D. I., Hollander H., Levy J. A. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis. 1987 Mar;155(3):475–481. doi: 10.1093/infdis/155.3.475. [DOI] [PubMed] [Google Scholar]
  6. Herskowitz A., Wu T. C., Willoughby S. B., Vlahov D., Ansari A. A., Beschorner W. E., Baughman K. L. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol. 1994 Oct;24(4):1025–1032. doi: 10.1016/0735-1097(94)90865-6. [DOI] [PubMed] [Google Scholar]
  7. Himelman R. B., Chung W. S., Chernoff D. N., Schiller N. B., Hollander H. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1989 Apr;13(5):1030–1036. doi: 10.1016/0735-1097(89)90256-8. [DOI] [PubMed] [Google Scholar]
  8. Himelman R. B., Dohrmann M., Goodman P., Schiller N. B., Starksen N. F., Warnock M., Cheitlin M. D. Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. Am J Cardiol. 1989 Dec 1;64(19):1396–1399. doi: 10.1016/0002-9149(89)90594-8. [DOI] [PubMed] [Google Scholar]
  9. Jacob A. J., Sutherland G. R., Bird A. G., Brettle R. P., Ludlam C. A., McMillan A., Boon N. A. Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J. 1992 Dec;68(6):549–553. doi: 10.1136/hrt.68.12.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kinney E. L., Monsuez J. J., Kitzis M., Vittecoq D. Treatment of AIDS-associated heart disease. Angiology. 1989 Nov;40(11):970–976. doi: 10.1177/000331978904001106. [DOI] [PubMed] [Google Scholar]
  11. Klein R. S., Harris C. A., Small C. B., Moll B., Lesser M., Friedland G. H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 9;311(6):354–358. doi: 10.1056/NEJM198408093110602. [DOI] [PubMed] [Google Scholar]
  12. Melbye M., Grossman R. J., Goedert J. J., Eyster M. E., Biggar R. J. Risk of AIDS after herpes zoster. Lancet. 1987 Mar 28;1(8535):728–731. doi: 10.1016/s0140-6736(87)90365-5. [DOI] [PubMed] [Google Scholar]
  13. Moss A. R., Bacchetti P., Osmond D., Krampf W., Chaisson R. E., Stites D., Wilber J., Allain J. P., Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):745–750. doi: 10.1136/bmj.296.6624.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Peters B. S., Beck E. J., Coleman D. G., Wadsworth M. J., McGuinness O., Harris J. R., Pinching A. J. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ. 1991 Jan 26;302(6770):203–207. doi: 10.1136/bmj.302.6770.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Phillips A. N., Lee C. A., Elford J., Janossy G., Timms A., Bofill M., Kernoff P. B. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991 Feb 16;337(8738):389–392. doi: 10.1016/0140-6736(91)91166-r. [DOI] [PubMed] [Google Scholar]
  16. Willoughby S. B., Vlahov D., Herskowitz A. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. Am J Cardiol. 1993 Feb 15;71(5):446–447. doi: 10.1016/0002-9149(93)90451-h. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES